Tobacco Use Disorder Clinical Trial
Official title:
Progesterone and the Effects of Nicotine
Past research on nicotine addiction has shown that changes in estradiol and progesterone hormone levels during menstruation may cause women to respond differently than men to nicotine. The purpose of this study is to examine the effects of progesterone on smoking behavior, nicotine withdrawal symptoms, and the reinforcing effects of smoking in men and women addicted to nicotine.
Nicotine addiction is a serious health problem. Almost 35 million people in the United States
try to quit smoking each year, but less than 7 percent are successful. Many smokers report a
"high" sensation, followed by a feeling of relaxation. Such positive reinforcement factors,
combined with nicotine cravings, make it difficult to stop the use of nicotine products. Past
research has suggested that women may experience fewer nicotine cravings and may be less
affected by smoking's positive reinforcement factors when compared to men. Fluctuations in
levels of the female hormones estradiol and progesterone during menstruation may play a role
in determining how women are affected by nicotine. The purpose of this study is to examine
the effects of a controlled oral dose of progesterone on smoking behavior, nicotine
withdrawal symptoms, and nicotine-related positive reinforcement factors in nicotine
dependent males and females.
In this 4-day study, participants will be randomly assigned to receive a daily dose of 200 mg
of progesterone, 400 mg of progesterone, or placebo. All participants will abstain from
smoking for Days 1 through 3. On Day 4, participants will take part in a smoking session,
during which their smoking habits, including the number of puffs, duration of puffs, and
number of cigarettes smoked, will be measured. Outcome measurements will include self-reports
of cravings; carbon monoxide monitoring; and standardized questionnaires to assess nicotine
withdrawal symptoms.
This study has been completed with 35 men and 30 women. With the final women completing in
March of 2008. This protocol is complete and has been published.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02432066 -
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
|
Phase 2 | |
Completed |
NCT03960138 -
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Completed |
NCT04646668 -
Comparative Abuse Liability Among African American and White Smokers
|
N/A | |
Completed |
NCT02560324 -
Effect of Ramelteon on Smoking Abstinence
|
Phase 2 | |
Completed |
NCT02347605 -
Medicinal Nicotine for Preventing Cue Induced Craving
|
N/A | |
Completed |
NCT01428310 -
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
|
Phase 1 | |
Completed |
NCT01442753 -
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
|
N/A | |
Completed |
NCT01625767 -
Tobacco Approach Avoidance Training for Adolescent Smokers-1
|
Phase 2 | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Terminated |
NCT01800500 -
Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
|
N/A | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT01337817 -
A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers
|
Phase 1 | |
Completed |
NCT00967005 -
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
|
Phase 2 | |
Active, not recruiting |
NCT00751660 -
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
|
N/A | |
Completed |
NCT00790569 -
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
|
N/A | |
Completed |
NCT00664261 -
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
|
N/A | |
Completed |
NCT00134927 -
A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches
|
N/A | |
Completed |
NCT00158158 -
Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2
|
Phase 2/Phase 3 | |
Completed |
NCT00218179 -
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
|
N/A |